KIM AUSTIN D.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$1.9M

Insider Activity of KIM AUSTIN D.

According to the SEC Form 4 filings, KIM AUSTIN D., being in a position of

  1. EVP,General Counsel, Secretary at ACADIA Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 590 shares for $17,676,
    over all time since 2019-12-11, has bought 0 shares, and sold 54135 shares for $1.9M.

The largest sale of all time was on 2019-12-11 and amounted to 17500 shares of ACADIA Pharmaceuticals Inc. for $788,576.

Biography of KIM AUSTIN D.

No biography is available at this moment.

2024-01-08SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
590
0.0004%
$29.96$17,676-43.59%
2023-10-06SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
16,369
0.0101%
$21.96$359,463-13.56%
2023-05-01SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
917
0.0006%
$21.18$19,422+10.67%
2023-04-06SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
1,456
0.0009%
$18.16$26,441+31.17%
2023-02-24SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
803
0.0005%
$18.78$15,080+26.85%
2023-01-09SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
589
0.0004%
$17.13$10,090+34.98%
2022-04-29SaleACADIA Pharmaceuticals Inc.
ACAD
EVP,General Counsel, Secretary
894
0.0005%
$18.18$16,255-8.95%
2022-02-23SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
782
0.0005%
$23.80$18,612-32%
2022-01-06SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
574
0.0004%
$23.05$13,231-28.22%
2021-04-30SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
1,054
0.0006%
$20.33$21,428+6.52%
2021-02-04SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
2,107
0.0013%
$50.61$106,635-57.96%
2021-01-06SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
678
0.0004%
$53.34$36,165-59.88%
2020-10-27SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
8,750
0.0053%
$45.10$394,636-47.63%
2020-04-30SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
1,072
0.0007%
$49.22$52,764-2.75%
2019-12-11SaleACADIA Pharmaceuticals Inc.
ACAD
EVP & General Counsel
17,500
0.0113%
$45.06$788,576-2.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.